ArticleFuture oncology (London, England)2026
Effectiveness of daratumumab plus bortezomib, lenalidomide, and dexamethasone (DVRd) versus VRd for transplant-eligible newly diagnosed multiple myeloma.
Carlyn Rose Tan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.